Radiant Donated Tk 1 Crore to Chief Advisor's Relief Fund to Flood Victims
4 September, 2024

Radiant Group Donated Tk 1 Crore to Chief Advisor’s Relief Fund to Aid the Flood Victims

Share

Radiant Pharmaceuticals Limited, along with its affiliate companies, has made a significant contribution of Tk 1 crore to the Chief Advisor’s Relief Fund to assist the victims of the recent floods in the Feni, Noakhali, and Cumilla districts.

This donation reflects Radiant Group’s deep commitment to corporate social responsibility (CSR) and our dedication to supporting communities during times of crisis.

As a leading healthcare organization, Radiant Group recognizes the importance of swift and effective action in disaster relief.

We hope this contribution will provide much-needed assistance to those affected, helping to restore lives and rebuild communities in the aftermath of this devastating natural disaster.

Our thoughts are with all those impacted, and we will continue to explore ways to contribute to the welfare of the nation.

Share
Radiant Donated Tk 1 Crore to Chief Advisor's Relief Fund to Flood Victims
Table of Contents

Radiant Pharmaceuticals Limited, along with its affiliate companies, has made a significant contribution of Tk 1 crore to the Chief Advisor’s Relief Fund to assist the victims of the recent floods in the Feni, Noakhali, and Cumilla districts.

This donation reflects Radiant Group’s deep commitment to corporate social responsibility (CSR) and our dedication to supporting communities during times of crisis.

As a leading healthcare organization, Radiant Group recognizes the importance of swift and effective action in disaster relief.

We hope this contribution will provide much-needed assistance to those affected, helping to restore lives and rebuild communities in the aftermath of this devastating natural disaster.

Our thoughts are with all those impacted, and we will continue to explore ways to contribute to the welfare of the nation.

Table of Contents

Confidentiality Note:

Any information related to the identities of the patient and reporter will be kept confidential unless it is subject to disclose due to regulatory obligation.

AcceptDecline